We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > OmniAb

News List

Ligand Pharmaceuticals Appoints Jennifer Cochran to its Board of Directors firstwordpharma
July 15, 2021
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) ("Ligand" or "the Company")announces the appointment of Jennifer Cochran, Ph.D. to the Company's Board of Directors
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement prnasia
June 03, 2021
GenScript Biotech Corporation along with its subsidiary, GenScript ProBio, and Ligand Pharmaceuticals Incorporated announced that they have entered into a strategic licensing agreement for Ligand's OmniAb® Platform, a multi-species antibody discovery ...
Ligand Announces OmniAb Partnership with Genagon Therapeutics americanpharmaceuticalreview
February 14, 2019
Ligand Pharmaceuticals has entered into a worldwide OmniAb partnership with Genagon Therapeutics AB, an immuno-oncology focused biotech located in Sweden.....